mAbxience

A global biopharmaceutical company specialized in research, development and manufacturing of biosimilars for the treatment.

mAbxience is a biotechnology company specialising in the research, development and manufacture of biologic products, mainly biosimilar drugs. Established in Europe in 2009, they are a multinational group that operates internationally and enjoys a strong presence in the major pharmaceutical markets. mAbxience is also fully committed to high-quality products and processes that meet regulatory and technical requirements in all countries in which they operate. They currently have two fully developed biosimilars already marketed as well as four in the developmental phase.